Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, Retinaldehyde-binding protein 1 | 0 | 0 | 1 | 1 |
Chain A, Retinaldehyde-binding protein 1 | 0 | 0 | 1 | 1 |
Histone deacetylase 3 | 0 | 5 | 0 | 5 |
Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
Histone deacetylase 4 | 0 | 5 | 0 | 5 |
Histone deacetylase 1 | 0 | 5 | 1 | 6 |
Histone deacetylase 7 | 0 | 4 | 0 | 4 |
Histone deacetylase 2 | 0 | 6 | 0 | 6 |
Polyamine deacetylase HDAC10 | 0 | 4 | 0 | 4 |
Histone deacetylase 11 | 0 | 4 | 0 | 4 |
Histone deacetylase 8 | 0 | 5 | 0 | 5 |
Histone deacetylase 6 | 0 | 6 | 1 | 7 |
Histone deacetylase 9 | 0 | 4 | 0 | 4 |
Histone deacetylase 5 | 0 | 4 | 0 | 4 |
PPM1D protein | 3 | 0 | 0 | 3 |
EWS/FLI fusion protein | 6 | 0 | 0 | 6 |
Histone deacetylase 6 | 0 | 1 | 0 | 1 |
interferon gamma precursor | 0 | 0 | 0 | 2 |
Interferon beta | 5 | 0 | 0 | 5 |
Leukotriene A-4 hydrolase | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-5 | 0 | 3 | 0 | 3 |
NAD-dependent protein deacetylase sirtuin-2 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-1 | 0 | 1 | 0 | 1 |
Nuclear receptor corepressor 2 | 0 | 2 | 0 | 2 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 3 | 0 | 0 | 3 |
Chain A, MTA/SAH nucleosidase | 0 | 1 | 0 | 1 |
Chain A, Ribosome-inactivating protein alpha-trichosanthin | 0 | 0 | 1 | 1 |
Chain A, Ricin A chain | 0 | 0 | 1 | 1 |
Chain A, Ribosome-inactivating protein 3 | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
RAR-related orphan receptor gamma | 6 | 0 | 0 | 6 |
TDP1 protein | 8 | 0 | 0 | 8 |
AR protein | 10 | 0 | 0 | 10 |
nuclear receptor subfamily 1, group I, member 3 | 4 | 0 | 0 | 4 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 4 | 0 | 0 | 4 |
glucocorticoid receptor [Homo sapiens] | 6 | 0 | 0 | 6 |
estrogen-related nuclear receptor alpha | 6 | 0 | 0 | 6 |
pregnane X nuclear receptor | 4 | 0 | 0 | 4 |
estrogen nuclear receptor alpha | 10 | 0 | 0 | 10 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 6 | 0 | 0 | 6 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 2 | 0 | 0 | 2 |
heat shock protein beta-1 | 5 | 0 | 0 | 5 |
importin subunit beta-1 isoform 1 | 3 | 0 | 0 | 3 |
snurportin-1 | 3 | 0 | 0 | 3 |
tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
lamin isoform A-delta10 | 4 | 0 | 0 | 4 |
Voltage-dependent calcium channel gamma-2 subunit | 4 | 0 | 0 | 4 |
Bile salt export pump | 0 | 2 | 0 | 2 |
Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
Heat shock protein HSP 90-beta | 0 | 1 | 0 | 1 |
Glutamate receptor 2 | 4 | 0 | 0 | 4 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
Leucine-rich repeat serine/threonine-protein kinase 2 | 0 | 2 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 4 | 0 | 0 | 4 |
Ataxin-2 | 5 | 0 | 0 | 5 |
retinoic acid nuclear receptor alpha variant 1 | 6 | 0 | 0 | 6 |
thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
thyroid hormone receptor beta isoform 2 | 8 | 0 | 0 | 8 |
Heat shock protein HSP 90-alpha | 0 | 0 | 1 | 1 |
Botulinum neurotoxin type A | 0 | 1 | 0 | 1 |
Neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
Nitric oxide synthase, endothelial | 0 | 1 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase alpha | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase type 2-beta | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-kinase type 2-alpha | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-kinase beta | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-11 | 0 | 1 | 0 | 1 |
Fumarate hydratase | 3 | 0 | 0 | 3 |
aldehyde dehydrogenase 1 family, member A1 | 5 | 0 | 0 | 5 |
polyprotein | 3 | 0 | 0 | 3 |
euchromatic histone-lysine N-methyltransferase 2 | 4 | 0 | 0 | 4 |
vitamin D3 receptor isoform VDRA | 3 | 0 | 0 | 3 |
survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
Calpain-9 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-7 | 0 | 1 | 0 | 1 |
Cathepsin B | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
Aromatase | 0 | 2 | 0 | 2 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Calpain-2 catalytic subunit | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-1 | 0 | 2 | 0 | 2 |
Proteasome subunit alpha type-1 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-2 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-3 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-4 | 0 | 1 | 0 | 1 |
NF-kappa-B inhibitor alpha | 0 | 0 | 1 | 1 |
Proteasome subunit beta type-8 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-9 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-5 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-4 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-6 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-10 | 0 | 1 | 0 | 1 |
Cathepsin K | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-3 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-2 | 0 | 2 | 0 | 2 |
Proteasome subunit alpha type-6 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha-type 8 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-7 | 0 | 1 | 0 | 1 |
Gamma-secretase subunit PEN-2 | 0 | 1 | 0 | 1 |
GLI family zinc finger 3 | 5 | 0 | 0 | 5 |
IDH1 | 3 | 0 | 0 | 3 |
geminin | 4 | 0 | 0 | 4 |
Deoxycytidine kinase | 0 | 0 | 0 | 1 |
USP1 protein, partial | 5 | 0 | 0 | 5 |
Microtubule-associated protein tau | 3 | 0 | 0 | 3 |
activating transcription factor 6 | 3 | 0 | 0 | 3 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 3 | 0 | 0 | 3 |
Rap guanine nucleotide exchange factor 3 | 2 | 0 | 0 | 2 |
Cellular tumor antigen p53 | 6 | 0 | 0 | 6 |
Glutathione S-transferase P | 0 | 1 | 0 | 1 |
Alpha-tocopherol transfer protein | 0 | 0 | 1 | 1 |
thioredoxin reductase | 3 | 0 | 0 | 3 |
ATAD5 protein, partial | 2 | 0 | 0 | 2 |
D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
serine/threonine-protein kinase mTOR isoform 1 | 3 | 0 | 0 | 3 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 4 | 0 | 4 |
Interstitial collagenase | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 4 | 0 | 4 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2B adrenergic receptor | 0 | 4 | 0 | 4 |
Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 4 | 0 | 4 |
Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-1D adrenergic receptor | 0 | 6 | 0 | 7 |
5-hydroxytryptamine receptor 2C | 0 | 4 | 0 | 4 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 2 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 2 |
Alpha-synuclein | 1 | 2 | 0 | 3 |
5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
Alpha-1A adrenergic receptor | 0 | 3 | 1 | 4 |
D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 3 | 0 | 3 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
Chain A, Protein (peroxisome Proliferator Activated Receptor (ppar-delta)) | 0 | 1 | 0 | 1 |
phosphopantetheinyl transferase | 4 | 0 | 0 | 4 |
GLS protein | 2 | 0 | 0 | 2 |
regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
peroxisome proliferator activated receptor gamma | 6 | 0 | 0 | 6 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Trypsin | 0 | 1 | 0 | 1 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Coagulation factor VII | 0 | 1 | 0 | 1 |
Tissue factor | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-alpha | 0 | 2 | 0 | 2 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Oxoeicosanoid receptor 1 | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
Chain A, HADH2 protein | 1 | 0 | 0 | 1 |
Chain B, HADH2 protein | 1 | 0 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
Chain A, Cruzipain | 2 | 0 | 0 | 2 |
acid sphingomyelinase | 1 | 0 | 0 | 1 |
interleukin 8 | 3 | 0 | 0 | 3 |
acetylcholinesterase | 4 | 0 | 0 | 4 |
glp-1 receptor, partial | 1 | 0 | 0 | 1 |
BRCA1 | 1 | 0 | 0 | 1 |
15-lipoxygenase, partial | 3 | 0 | 0 | 3 |
pregnane X receptor | 3 | 0 | 0 | 3 |
hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
SMAD family member 2 | 3 | 0 | 0 | 3 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
SMAD family member 3 | 3 | 0 | 0 | 3 |
Thrombopoietin | 1 | 0 | 0 | 1 |
Smad3 | 1 | 0 | 0 | 1 |
caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 4 | 0 | 0 | 4 |
progesterone receptor | 2 | 0 | 0 | 2 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
retinoid X nuclear receptor alpha | 5 | 0 | 0 | 5 |
farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
G | 2 | 0 | 0 | 2 |
cytochrome P450 2D6 | 2 | 0 | 0 | 2 |
67.9K protein | 1 | 0 | 0 | 1 |
glucocerebrosidase | 2 | 0 | 0 | 2 |
Parkin | 1 | 0 | 0 | 1 |
P53 | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 4 | 0 | 0 | 4 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 4 | 0 | 0 | 4 |
caspase-3 | 2 | 0 | 0 | 2 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 2 | 0 | 0 | 2 |
nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
Caspase-7 | 2 | 0 | 0 | 2 |
Bloom syndrome protein isoform 1 | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 2 | 0 | 0 | 2 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform a | 1 | 0 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 3 | 0 | 0 | 3 |
caspase-3 | 2 | 0 | 0 | 2 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
huntingtin isoform 2 | 1 | 0 | 0 | 1 |
mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
flap endonuclease 1 | 1 | 0 | 0 | 1 |
ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 4 | 0 | 0 | 4 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 3 | 0 | 0 | 3 |
peripheral myelin protein 22 | 2 | 0 | 0 | 2 |
cytochrome P450 3A4 isoform 1 | 3 | 0 | 0 | 3 |
M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
lethal factor (plasmid) | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 3 | 0 | 0 | 3 |
Glycoprotein hormones alpha chain | 1 | 0 | 0 | 1 |
HLA class I histocompatibility antigen, B alpha chain | 2 | 0 | 0 | 2 |
Retinol-binding protein 4 | 0 | 0 | 3 | 3 |
Integrin beta-3 | 2 | 0 | 0 | 2 |
Prosaposin | 0 | 0 | 1 | 1 |
Integrin alpha-IIb | 2 | 0 | 0 | 2 |
Retinoic acid receptor gamma | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit delta | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 3 | 0 | 0 | 3 |
5-hydroxytryptamine receptor 1A | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 3 | 0 | 0 | 3 |
Retinoic acid receptor RXR-beta | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 3 | 0 | 0 | 3 |
Retinoic acid receptor RXR-gamma | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-3 | 3 | 0 | 0 | 3 |
Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-2 | 3 | 0 | 0 | 3 |
Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
GABA theta subunit | 3 | 0 | 0 | 3 |
Inositol hexakisphosphate kinase 1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | 3 | 0 | 0 | 3 |
cytochrome P450 2C9, partial | 2 | 0 | 0 | 2 |
guanine nucleotide-binding protein subunit alpha-15 | 0 | 1 | 1 | 2 |
trace amine-associated receptor 1 | 0 | 1 | 1 | 2 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 2 | 0 | 2 |
Spike glycoprotein | 2 | 0 | 1 | 3 |
Nischarin | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 1 | 0 | 1 |
Spike glycoprotein | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
Procathepsin L | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Cyclic GMP-AMP synthase | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
Toll-like receptor 9 | 0 | 1 | 0 | 1 |
Toll-like receptor 7 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 1 | 0 | 1 |
Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 2 | 2 |
retinoic acid receptor alpha isoform 1 | 0 | 1 | 0 | 1 |
retinoic acid receptor RXR-alpha isoform a | 0 | 1 | 0 | 1 |
Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
Chain A, Cellular retinoic acid-binding protein 2 | 0 | 0 | 1 | 1 |
Chain A, Cellular retinoic acid-binding protein 2 | 0 | 0 | 1 | 1 |
Luciferase | 1 | 0 | 0 | 1 |
Histone H2A.x | 1 | 0 | 0 | 1 |
Aldo-keto reductase family 1 member B10 | 0 | 0 | 0 | 2 |
Amyloid-beta precursor protein | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 0 | 0 | 1 |
Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR | 0 | 0 | 1 | 1 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
Beta-lactoglobulin | 0 | 0 | 1 | 1 |
Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
Retinoid isomerohydrolase | 0 | 1 | 0 | 1 |
Aspartyl/asparaginyl beta-hydroxylase | 0 | 1 | 0 | 1 |
HD2 type histone deacetylase HDA106 | 0 | 1 | 0 | 1 |
aryl hydrocarbon receptor | 1 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |